Edesa Biotech Inc (EDSA)
4.65
+0.13
(+2.88%)
USD |
NASDAQ |
May 17, 16:00
4.65
0.00 (0.00%)
After-Hours: 20:00
Edesa Biotech Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.0014M |
| March 31, 2022 | -0.0012M |
| December 31, 2021 | -0.0031M |
| September 30, 2021 | 0.0015M |
| June 30, 2021 | -0.0035M |
| March 31, 2021 | -0.003M |
| December 31, 2020 | -0.0011M |
| September 30, 2020 | 0.0035M |
| June 30, 2020 | -0.0268M |
| March 31, 2020 | 0.5197M |
| December 31, 2019 | -0.4773M |
| March 31, 2019 | 1.539M |
| December 31, 2018 | 4.473M |
| September 30, 2018 | -0.6359M |
| June 30, 2018 | -5.119M |
| March 31, 2018 | 0.3278M |
| December 31, 2017 | 0.9611M |
| September 30, 2017 | 1.901M |
| June 30, 2017 | -0.0768M |
| Date | Value |
|---|---|
| March 31, 2017 | -0.0432M |
| December 31, 2016 | -0.0892M |
| September 30, 2016 | -2.097M |
| June 30, 2016 | -0.0982M |
| March 31, 2016 | 2.929M |
| December 31, 2015 | -0.1766M |
| September 30, 2015 | -0.0811M |
| June 30, 2015 | -0.1565M |
| March 31, 2015 | -0.0428M |
| December 31, 2014 | 0.4028M |
| August 31, 2014 | -5.467M |
| May 31, 2014 | -0.0344M |
| February 28, 2014 | -0.2314M |
| November 30, 2013 | -0.0133M |
| August 31, 2013 | -0.0071M |
| May 31, 2013 | 0.00 |
| February 28, 2013 | 0.00 |
| November 30, 2012 | -0.0024M |
| August 31, 2012 | -0.0522M |
| May 31, 2012 | -0.0146M |
| February 29, 2012 | -0.0031M |
| November 30, 2011 | -0.0085M |
| August 31, 2011 | -0.0533M |
| May 31, 2011 | -0.0107M |
| February 28, 2011 | -0.0481M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.4773M
Minimum
Dec 2019
0.5197M
Maximum
Mar 2020
0.0005M
Average
-0.0006M
Median
Cash from Investing (Quarterly) Benchmarks
| Acasti Pharma Inc | -6.554M |
| Aurinia Pharmaceuticals Inc | -6.257M |
| Lexaria Bioscience Corp | -0.057M |
| Xenon Pharmaceuticals Inc | -46.20M |
| ESSA Pharma Inc | 62.51M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.660M |
| Cash from Financing (Quarterly) | 0.2117M |
| Free Cash Flow | -6.340M |
| Free Cash Flow Per Share (Quarterly) | -0.52 |
| Free Cash Flow Yield | -45.21% |